
A study of over 2,200 participants from the Northern Finland Birth Cohort 1966 found that habitual coffee drinkers tend to have lower visceral fat and higher skeletal muscle mass.
Higher coffee intake was associated with lower circulating levels of branched-chain amino acids, a biomarker linked to increased risks of obesity, type 2 diabetes, and heart disease.
Researchers noted that while coffee consumption correlates with a leaner body profile, BMI alone may not capture these metabolic differences, suggesting coffee's bioactive compounds play a role in cardiometabolic health.